Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
Clinical trial NCT03964727 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03964727
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-15
- Primary completion
- 2025-01-15
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.